Beyond Either/Or: Building Integrated Treatment Plans with Energy-Based Devices and Injectables

By Taylor Siemens, NP-C, Owner, Kairos Aesthetic Medicine

One of the biggest gaps I see in aesthetic treatment planning is not a lack of treatment options. It is the tendency to evaluate those options independently.

Does this patient need filler? Should we use a laser? Would a biostimulatory injectable be better? Is it time for neuromodulator?

In reality, aging rarely happens in one tissue compartment, so our treatment plans should not be built around a single modality either.

Patients experience changes in skin quality, collagen, pigmentation, vascularity, facial volume, skeletal support, fat distribution, and muscular movement—often simultaneously. When we begin to evaluate the face through that broader lens, energy-based devices and injectables stop competing with one another and instead become complementary tools within the same strategy.

The goal is not to determine whether a patient needs an injectable or a device. The goal is to identify what is changing anatomically and physiologically, then select the right tool for each layer.

Start With the Problem, Not the Product

Before choosing a treatment, I like to evaluate patients through three broad categories: Skin. Structure. Movement.

Skin encompasses the qualities we often see first: pigmentation, vascularity, texture, pore size, photodamage, laxity, and overall skin quality.

Structure includes volume, support, contour, fat redistribution, and the deeper changes that affect facial shape.

Movement refers to dynamic muscle activity and the repetitive patterns that contribute to expression lines and changes in facial balance.

No single treatment addresses all three categories equally well. Energy-based technologies can be incredibly effective for improving skin quality, stimulating collagen, addressing pigment and vascular concerns, and creating controlled remodeling within targeted tissue depths. Injectables offer an entirely different set of tools. Neuromodulators can alter excessive muscular contraction. Hyaluronic acid fillers can restore or reposition volume and support. Biostimulatory injectables can improve tissue quality and stimulate collagen production in appropriately selected patients.

The art of combination treatment planning is understanding where each modality contributes—and, just as importantly, where it does not.

Do Not Use Filler to Solve a Skin Problem

One of the simplest ways I think about combination treatment planning is this:

Do not fill a problem that is primarily a skin-quality problem.

A patient may present saying they look tired, older, or less vibrant and assume they need filler. But on assessment, a significant portion of what is aging their appearance may be pigmentation issues, rough texture, enlarged pores, photodamage, or loss of skin luminosity.

Adding volume does not correct those concerns. And in some cases, it can even create a fuller face without solving the thing the patient actually dislikes. Improving skin quality changes the way light reflects from the face. It can improve contrast, texture, tone, and overall visual age in a way that injectables simply cannot replicate.

That does not mean filler is unnecessary. It means filler should be reserved for the structural problem it is actually designed to treat. If the problem is pigment, treat pigment. If the problem is texture, treat texture. If the problem is vascularity, treat vascularity. If the problem is support, then consider structural correction. The treatment should match the tissue.

And Do Not Ask a Device to Rebuild Structure

The opposite mistake happens just as frequently. A patient may have excellent skin quality and still demonstrate clear structural aging through the temples, midface, chin, jawline, or perioral region. No amount of resurfacing can recreate skeletal support or replace meaningful volume loss. This is where device-only treatment plans can fall short. We should not expect a laser or other energy-based modality to perform the job of structural correction any more than we should expect filler to erase photodamage. Energy-based devices and injectables become powerful together precisely because they are solving different problems.

Think in Layers

Combination treatment planning becomes much simpler when we stop asking

“What treatment should I do?”

And instead ask: “What tissue am I trying to change?”

Consider a patient with photodamage, early skin laxity, and midface volume loss. An energy-based device may address the pigment and skin remodeling components. Injectable treatment may separately restore support in the midface. Those treatments are not redundant. They are addressing different contributors to the same overall complaint.

Or consider a patient with etched lines. If those lines are the result of both repetitive movement and changes in dermal quality, treating only the line itself may not be enough. Neuromodulator may address the dynamic component while an energy-based treatment improves the skin environment in which that line exists.

Lower-face aging is another good example. A patient may point to marionette lines or the jawline and ask for filler. But the visible concern may actually represent a combination of skin laxity, volume redistribution, structural change, and muscular activity. Trying to correct all of that with one syringe is rarely the best answer.

When the aging process is layered, the treatment plan should be layered too.

Sometimes Better Skin Means Less Filler

This is one of the most important lessons combination treatment planning has taught me. Patients do not always need as much injectable treatment as we initially think. When skin quality improves, the entire face can appear healthier, smoother, brighter, and more youthful. The perceived need for volume can decrease. This is especially important in an era where many patients are increasingly concerned about looking “overfilled.”

The answer is not necessarily to stop using filler. The answer is to stop asking filler to do too many jobs. If we improve the canvas first—or alongside structural correction—we can often be more conservative with volume and still create a stronger overall result.

Sequencing Matters, but There Is No Universal Formula

Combination therapy is not simply performing multiple treatments. It requires intentional sequencing.

Before building a treatment series, I ask several questions:

What tissue is being targeted by each modality?

How much heat, inflammation, edema, or tissue manipulation should I expect?

Will one treatment temporarily alter the anatomy I need to evaluate for the next?

Does one treatment depend on precise visualization or palpation of facial structures?

Could the timing of one treatment theoretically affect another treatment?

What recovery burden is realistic for this particular patient?

This is why I am cautious with blanket rules such as “always do devices first” or “always inject first.” There is no universal sequence that applies to every device, every injectable, every anatomical area, and every patient. A superficial light-based treatment and a deeper resurfacing procedure are not interchangeable. A neuromodulator and a volumizing injectable are not interchangeable. A minimally inflammatory treatment and one that creates significant edema are not interchangeable.

Sequencing should be based on tissue targets, depth, expected inflammatory response, treatment area, manufacturer guidance, and the individual patient.

Combination Treatment Does Not Mean More Treatment

Comprehensive treatment planning should not become an excuse to perform every treatment available. In fact, good combination planning should often help us do less. Improving skin quality may reduce the amount of filler a patient needs. Restoring appropriate structural support may reduce the temptation to chase every superficial crease with additional product.

Managing excessive muscle movement may improve the longevity and appearance of other treatments. Collagen stimulation may allow us to support tissue quality instead of repeatedly reacting to individual lines. The goal is not maximal intervention. It is strategic intervention.

The best combination plan is not the plan with the most modalities. It is the plan in which every modality has a clear purpose.

The Future of Aesthetic Treatment Planning Is Integrated

As our industry evolves, practitioners have access to more injectable products, energy-based technologies, regenerative treatments, and combination strategies than ever before. The challenge is no longer simply learning how to use each tool. The greater challenge is knowing when to use each one, when not to use it, and how to combine modalities without losing sight of the patient.

That requires moving beyond product-centered and device-centered thinking. When we approach aesthetic medicine this way, energy-based devices and injectables stop being competing categories. They become different instruments within the same treatment plan—and the result is care that is more precise, more conservative, more comprehensive, and ultimately more aligned with the way our patients actually age.

Taylor Siemens, NP-C, is a nationally recognized nurse practitioner, aesthetic medicine expert and industry educator with a decade of experience in medical aesthetics. She specializes in laser medicine, advanced energy-based devices, injectables and combination treatment planning, with a strong focus on patient safety, outcomes and clinical integrity. Siemens has worked across facial plastics, multi-site med spa operations and private equity–backed organizations, giving her a rare perspective that bridges clinical excellence and scalable business strategy. She currently serves as a clinical advisor to AmSpa and speaks at more than 20 conferences annually, educating clinicians and practice owners on laser safety, advanced treatment protocols and sustainable growth. As the founder of Kairos Aesthetic Medicine and Kairos Aesthetic Training, Siemens is passionate about elevating standards of care, empowering providers through education and helping practices deliver results that are both clinically grounded and aesthetically driven.